Related Experiment Video
Updated: Jun 26, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity
Junjiang Fu1, Jun Jiang, Jiwen Li
1The Institute of Biomedical Sciences, College of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China.
Abstract:
Androgen receptor (AR) plays a critical role in development and maintenance of male reproductive functions and the etiology of prostate cancer. As a ligand-regulated transcription factor, identification and characterization of AR coregulators are essential for understanding the molecular mechanisms underlying its diverse biological functions. Here we reported the identification of a novel AR coactivator, deleted in breast cancer 1 (DBC1), through a biochemical approach. DBC1 interacts with AR in a ligand-stimulated manner and facilitates AR transcriptional activation in transfected cells as well as in Xenopus oocytes. In in vitro gel shift experiments, recombinant DBC1 drastically enhanced AR DNA-binding activity. Expression of DBC1 also enhanced the binding of AR to chromatinized template in vivo, whereas knockdown of DBC1 impaired the binding of AR to endogenous prostate-specific antigen (PSA) gene in the prostate cancer cell line LNCaP. Thus, our data identify DBC1 as a novel AR coactivator.
Insights
Researchers discovered deleted in breast cancer 1 (DBC1) as a novel coactivator for the androgen receptor (AR). DBC1 enhances AR
Area of Science:
- Molecular Biology
- Endocrinology
- Cancer Research
Background:
- The androgen receptor (AR) is crucial for male reproductive functions and prostate cancer development.
- Understanding AR molecular mechanisms requires identifying its coregulators.
- AR functions as a ligand-regulated transcription factor.
Purpose of the Study:
- To identify and characterize novel coregulators of the androgen receptor.
- To investigate the role of deleted in breast cancer 1 (DBC1) as an AR coactivator.
Main Methods:
- Biochemical approaches were used for identification.
- Interaction studies in transfected cells and Xenopus oocytes.
- In vitro gel shift assays and in vivo chromatin binding experiments.
- Knockdown studies in LNCaP prostate cancer cells.
Main Results:
- Deleted in breast cancer 1 (DBC1) was identified as a novel AR coactivator.
- DBC1 interacts with AR in a ligand-dependent manner.
- DBC1 enhances AR transcriptional activity and DNA-binding.
- DBC1 facilitates AR binding to the prostate-specific antigen (PSA) gene promoter.
Conclusions:
- DBC1 is a novel coactivator that modulates androgen receptor activity.
- DBC1 plays a significant role in AR-mediated gene regulation, including the PSA gene.
- DBC1 represents a potential therapeutic target in prostate cancer.
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

